EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quinic and Ferulic Acid–Loaded Chitosan Nanoparticles Attenuate Experimental Ulcerative Colitis by Modulating the IL‐32/IL‐33/IL‐34 Axis and NF‐κB Signaling

Fatemeh Azadegan-Dehkordi iD, Hossein Aslani, Mehdi Badihi, Fatemeh Taheri iD, Pegah Khosravian-Dehkordi iD, Nader Bagheri iD

International Journal of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/ijin/7179301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Inflammation, online erschienen am 26.06.2026. Verfasst von Fatemeh Azadegan-Dehkordi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahrekord University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ulcerative colitis (UC) is characterized by immune dysregulation and localized inflammation of the colonic mucosa. Despite advances in therapy, effective treatment remains difficult. This study aimed to investigate the immunomodulatory and therapeutic effects of chitosan nanoparticles (CS‐NPs) loaded with quinic acid (QA) and ferulic acid (FA) in an experimental model of UC, focusing on the IL‐32/IL‐33/IL‐34 cytokine axis and the NF‐κB signaling pathway.

Methods

Eighty male Wistar rats were randomly divided into 10 groups ( n = 8 per group). Experimental acute colitis was induced in rats via intrarectal administration of 4% acetic acid (AA). After induction, the animals received CS‐NPs loaded with QA and FA for seven consecutive days. IL‐33, IL‐34, and NF‐κB mRNA expression were measured by real‐time PCR. Additionally, tissue IL‐32 levels were measured using an ELISA kit.

Results

Induction of UC significantly increased IL‐32 protein levels as well as the expression of IL‐33, IL‐34, and NF‐κB. Oral administration with mesalazine, FA/QA/CS‐NPs, QA/CS‐NPs, FA/CS‐NPs, FA/QA, QA, and FA significantly decreased IL‐32 protein levels and the expression of IL‐33, IL‐34, and NF‐κB relative to the model group.

Conclusion

FA/QA‐loaded CS‐NPs exhibit anti‐inflammatory effects in experimental UC, likely through modulation of the IL‐32/IL‐33/IL‐34 cytokine axis and NF‐κB signaling. These findings suggest that FA/QA/CS‐NPs may serve as a promising herbal‐based therapeutic candidate for the treatment of UC in humans.

Schlagwörter

Stichwörter der Autor:innen

IL-32/IL-33/IL-34 axisNF-κB pathwaychitosan nanoparticlesferulic acidinflammationquinic acidulcerative colitis

Autor:innen und Institutionen

  • Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.
  • Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.
  • Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.
  • Department of Pathology, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.
  • Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.
  • Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran, skums.ac.ir.

ORCID-Profile: Fatemeh Azadegan-Dehkordi, Fatemeh Taheri, Pegah Khosravian-Dehkordi, Nader Bagheri

Förderung

  • Shahrekord University of Medical Sciences

Zitieren

APA

Azadegan-Dehkordi, F., Aslani, H., Badihi, M., Taheri, F., Khosravian-Dehkordi, P., & Bagheri, N. (2026). Quinic and Ferulic Acid–Loaded Chitosan Nanoparticles Attenuate Experimental Ulcerative Colitis by Modulating the IL‐32/IL‐33/IL‐34 Axis and NF‐κB Signaling. International Journal of Inflammation, 2026(1). https://doi.org/10.1155/ijin/7179301

Vancouver

Azadegan-Dehkordi F, Aslani H, Badihi M, Taheri F, Khosravian-Dehkordi P, Bagheri N. Quinic and Ferulic Acid–Loaded Chitosan Nanoparticles Attenuate Experimental Ulcerative Colitis by Modulating the IL‐32/IL‐33/IL‐34 Axis and NF‐κB Signaling. International Journal of Inflammation. 2026;2026(1). doi:10.1155/ijin/7179301

BibTeX
@article{AzadeganDehkordi2026,
  author = {Azadegan-Dehkordi, Fatemeh and Aslani, Hossein and Badihi, Mehdi and Taheri, Fatemeh and Khosravian-Dehkordi, Pegah and Bagheri, Nader},
  title = {Quinic and Ferulic Acid–Loaded Chitosan Nanoparticles Attenuate Experimental Ulcerative Colitis by Modulating the IL‐32/IL‐33/IL‐34 Axis and NF‐κB Signaling},
  journal = {International Journal of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijin/7179301}
}
Kostenlos starten →